Charles Schwab Investment Management Inc Icosavax, Inc. Transaction History

Charles Schwab Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$5.95 - $15.79 $64,158 - $170,263	10,783 Added 15.01%	82,642 $1.3 Million
Q2 2023 Aug 09, 2023	BUY	$4.89 - $10.57 $64,186 - $138,741	13,126 Added 22.35%	71,859 $713,000
Q4 2022 Feb 13, 2023	BUY	$2.32 - $10.97 $22,954 - $108,537	9,894 Added 20.26%	58,733 $466,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $9.21 $14,315 - $42,669	-4,633 Reduced 8.66%	48,839 $155,000
Q2 2022 Aug 15, 2022	SELL	$5.7 - $10.33 $28,956 - $52,476	-5,080 Reduced 8.68%	53,472 $307,000
Q1 2022 May 13, 2022	BUY	$4.41 - $22.5 $109,456 - $558,450	24,820 Added 73.58%	58,552 $413,000
Q4 2021 Feb 11, 2022	BUY	$21.07 - $34.98 $20,543 - $34,105	975 Added 2.98%	33,732 $772,000
Q3 2021 Nov 16, 2021	BUY	$24.85 - $40.25 $814,011 - $1.32 Million	32,757 New	32,757 $970,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.